DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
We compared OTC testosterone-support supplements and telehealth options on evidence, dosing, value, and safety. Independent, clinician-reviewed.
We bought and tested the leading options, scoring each on effectiveness, safety, value, accessibility, user experience, and trust. Affiliate relationships never change the ranking — every pick below earned its place on the evidence.
Telehealth path from supplement to clinical TRT
Hims Testosterone Support is a telehealth program built around compounded enclomiphene, a prescription pill that prompts your body to make more of its own testosterone while preserving fertility. Randomized trials and a 2025 meta-analysis show it meaningfully raises testosterone (roughly +274 ng/dL versus placebo) to levels comparable with testosterone gel, but enclomiphene is not FDA-approved, is sold as a compounded drug, and is billed upfront for multiple months.
Fully-dosed, transparent-label T-support
Transparent Labs Vitality is a clinically-dosed, transparently-labeled herbal testosterone-support supplement combining KSM-66 ashwagandha, tongkat ali (LJ100), PrimaVie shilajit, DIM, quercetin, zinc, and boron. Studies on its individual ingredients show modest total-testosterone gains (shilajit raised total testosterone roughly 20% over 90 days in one trial) in stressed, fatigued, or aging men, but it is not a substitute for prescription testosterone therapy, and no published trial has tested the finished Vitality blend itself.
Best-known OTC testosterone support blend
Nugenix Total-T is an over-the-counter testosterone-support supplement, not a hormone or drug. A couple of its ingredients (boron and the branded Tesnor extract) are dosed in line with their cited research, but several others are underdosed, and large independent reviews find most 'T-boosters' lack proof that they meaningfully raise serum testosterone. It can be reasonable to trial for mild symptoms, but see a doctor and get a blood test for suspected true low testosterone.
No. The main ingredient, enclomiphene, is not FDA-approved; its new-drug application (Androxal) received an FDA Complete Response Letter in December 2015 asking for more Phase 3 data, and development was discontinued for all uses in 2021. Hims dispenses enclomiphene as a compounded medication, which the FDA does not review for safety, effectiveness, or quality.
For men with secondary hypogonadism, the evidence is reasonably strong. Randomized trials and a 2025 meta-analysis of 10 trials (819 men) show enclomiphene and related SERMs raise total testosterone by roughly 274 ng/dL versus placebo, to levels comparable with testosterone gel, while preserving sperm production. Individual results vary and depend on a clinician's dosing and monitoring.
TRT adds testosterone from outside the body, which can shut down natural production and reduce sperm counts. Enclomiphene instead signals your own testicles to make more testosterone and keeps fertility intact, making it a better fit for men who may want children. Enclomiphene is also not FDA-approved, whereas several TRT products are.
As of 2026, plans run about $99-$199 per month depending on length, paid upfront: roughly $199/month for a 3-month plan, $139/month for 5 months, and $99/month for 10 months. The price bundles medication, lab monitoring, and provider check-ins, but it's generally non-refundable and not covered by insurance. Confirm current pricing directly with Hims.
Enclomiphene is specifically chosen to preserve fertility. In Phase III data it caused only minimal change in sperm density (about 12-15%), while testosterone gel reduced it by roughly 33-57%, which is why it appeals to men who want to raise testosterone without compromising the ability to conceive. If you are actively trying to conceive, discuss timing and monitoring with your prescriber.